Dec 7 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL HAS RECEIVED FIRST RESULTS FROM LABORATORY TESTS OF
ARFOLITIXORIN
* FURTHER LABORATORY TESTS ARE ONGOING AND FULL RESULTS FROM
PRECLINICAL EVALUATION ARE EXPECTED TO BE DELIVERED IN EARLY
2024
* ISOFOL MEDICAL-DATA GENERATED SO FAR FROM FIRST
EXPERIMENTS SHOW
NO DIFFERENCE IN ADDITIONAL EFFECT OF ARFOLITIXORIN COMPARED TO
LEUCOVORIN
* HIGHER DOSES OF ARFOLITIXORIN THAN WAS USED IN AGENT STUDY
HAVE
BEEN TESTED, BUT WITH NO BETTER EFFECT
Source text for Eikon: ID:nWkrb9r1FM
Further company coverage: ISOFOL.ST
((Reuters.Briefs@thomsonreuters.com;))